These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24831287)

  • 1. A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.
    Oldenburg NC; Duval S; Luepker RV; Finnegan JR; LaMarre H; Peterson KA; Zantek ND; Jacobs G; Straka RJ; Miller KH; Hirsch AT
    Prev Chronic Dis; 2014 May; 11():E83. PubMed ID: 24831287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial.
    Luepker RV; Eder M; Finnegan JR; Van't Hof JR; Oldenburg N; Duval S
    JAMA Netw Open; 2022 May; 5(5):e2211107. PubMed ID: 35536579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of aspirin for prevention of cardiovascular disease--1981-82 to 1985-86: the Minnesota Heart Survey.
    Folsom AR; Iso H; Sprafka JM; Edlavitch SA; Luepker RV
    Am Heart J; 1988 Sep; 116(3):827-30. PubMed ID: 3261930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin Use and Awareness for Cardiovascular Disease Prevention Among Hispanics: Prevalence and Associations with Health Behavior Beliefs.
    Misialek JR; Van't Hof JR; Oldenburg NC; Jones C; Eder M; Luepker RV; Duval S
    J Community Health; 2020 Aug; 45(4):820-827. PubMed ID: 32112236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.
    Michaud TL; Abraham J; Jalal H; Luepker RV; Duval S; Hirsch AT
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?
    Fiscella K; Winters PC; Mendoza M; Noronha GJ; Swanger CM; Bisognano JD; Fortuna RJ
    J Gen Intern Med; 2015 Feb; 30(2):155-60. PubMed ID: 25092016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting.
    Carlton R; Coppolecchia R; Khalaf-Gillard K; Lennert B; Moradi A; Williamson T; Cameron J
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1102-1111. PubMed ID: 30362916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of acetylsalicylic acid by physicians and in the community.
    Mahon J; Steel K; Feagan BG; Laupacis A; Pederson LL
    CMAJ; 1991 Nov; 145(9):1107-16. PubMed ID: 1751930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey.
    Luepker RV; Steffen LM; Duval S; Zantek ND; Zhou X; Hirsch AT
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose aspirin for primary prevention of cardiovascular disease: Trends in use patterns among African American adults in Minnesota, 2015-2019.
    Van't Hof JR; Duval S; Oldenburg NC; Misialek JR; Eder MM; Jones C; Finnegan JR; Luepker RV
    Prev Med; 2021 Jul; 148():106589. PubMed ID: 33930435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
    Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
    Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study.
    Fernandez-Jimenez R; Wang TJ; Fuster V; Blot WJ
    J Am Heart Assoc; 2019 Dec; 8(24):e013404. PubMed ID: 31822218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study.
    Wu IC; Hsieh HM; Wu MT
    BMJ Open; 2015 Jan; 5(1):e006694. PubMed ID: 25575876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly).
    Silagy CA; McNeil JJ; Donnan GA; Tonkin AM; Worsam B; Campion K
    J Am Geriatr Soc; 1994 Jun; 42(6):643-7. PubMed ID: 8201151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Preventive Aspirin Among Older US Adults With and Without Diabetes.
    Liu EY; Al-Sofiani ME; Yeh HC; Echouffo-Tcheugui JB; Joseph JJ; Kalyani RR
    JAMA Netw Open; 2021 Jun; 4(6):e2112210. PubMed ID: 34152419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin Use for Cardiovascular Disease Prevention in an African American Population: Prevalence and Associations with Health Behavior Beliefs.
    Van't Hof JR; Duval S; Misialek JR; Oldenburg NC; Jones C; Eder M; Luepker RV
    J Community Health; 2019 Jun; 44(3):561-568. PubMed ID: 30895416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
    Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ
    Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.